BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27385018)

  • 1. Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.
    Mehta RS; Rezvani K
    Virulence; 2016 Nov; 7(8):901-916. PubMed ID: 27385018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.
    Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D
    Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution after hematopoietic cell transplantation.
    Bosch M; Khan FM; Storek J
    Curr Opin Hematol; 2012 Jul; 19(4):324-35. PubMed ID: 22517587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.
    Bejanyan N; Brunstein CG; Cao Q; Lazaryan A; Luo X; Curtsinger J; Mehta RS; Warlick E; Cooley SA; Blazar BR; Miller JS; Weisdorf D; Wagner JE; Verneris MR
    Blood Adv; 2018 Apr; 2(8):909-922. PubMed ID: 29678809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
    Szabolcs P; Mazor RD; Yackoubov D; Levy S; Stiff P; Rezvani A; Hanna R; Wagner J; Keating A; Lindemans CA; Karras N; McGuirk J; Hamerschlak N; López-Torija I; Sanz G; Valcarcel D; Horwitz ME
    Transplant Cell Ther; 2023 Aug; 29(8):517.e1-517.e12. PubMed ID: 37120136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate Immune Recovery Predicts CD4
    de Koning C; Langenhorst J; van Kesteren C; Lindemans CA; Huitema ADR; Nierkens S; Boelens JJ
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):819-826. PubMed ID: 30359735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
    Barron MA; Gao D; Springer KL; Patterson JA; Brunvand MW; McSweeney PA; Zeng C; Barón AE; Weinberg A
    Clin Infect Dis; 2009 Dec; 49(12):1777-83. PubMed ID: 19911937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic reconstitution after allogeneic stem cell transplant].
    Lacerda JF
    Acta Med Port; 2004; 17(6):471-80. PubMed ID: 16197859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation.
    Jandin A; Pochon C; Campidelli A; D'Aveni M; Kicki C; Notarantonio AB; Roth Guepin G; Mbuyi TA; Feugier P; Chastagner P; Schweitzer C; de Carvalho Bittencourt M; Rubio MT; Pagliuca S
    Br J Haematol; 2023 Jul; 202(1):122-134. PubMed ID: 37092504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
    Morecki S; Gelfand Y; Nagler A; Or R; Naparstek E; Varadi G; Engelhard D; Akerstein A; Slavin S
    Bone Marrow Transplant; 2001 Aug; 28(3):243-9. PubMed ID: 11535991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
    Buser A; Stern M; Arber C; Medinger M; Halter J; Rovo A; Favre G; Lohri A; Tichelli A; Gratwohl A
    Bone Marrow Transplant; 2008 Oct; 42(7):483-7. PubMed ID: 18695668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological reconstitution after hematopoietic cell transplantation - its relation to the contents of the graft.
    Storek J
    Expert Opin Biol Ther; 2008 May; 8(5):583-97. PubMed ID: 18407763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
    Williams KM; Gress RE
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):579-96. PubMed ID: 18790456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders.
    Bhatt ST; Bednarski JJ
    Front Immunol; 2020; 11():1988. PubMed ID: 33013851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation.
    Roberts MM; To LB; Gillis D; Mundy J; Rawling C; Ng K; Juttner CA
    Bone Marrow Transplant; 1993 Nov; 12(5):469-75. PubMed ID: 7905331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
    Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
    Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regeneration of the immune system after bone marrow transplantation].
    Uher F; Puskás E; Torbágyi E; Barta A; Kormos L; Pálóczi K
    Orv Hetil; 2001 Jan; 142(2):59-65. PubMed ID: 11209506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.